Dr. Seung Jun Yoo is currently the Chief Strategy Officer of Korea’s genome analytic technology company, GENINUS Inc. a spin-off from Samsung Medical Center. Previously he was the Chief Strategy and Business Officer for J. Young Healthcare. He also served Korea Bio-Economy Research Center at KoreaBIO (Korea Biotechnology Industry Organization) as the Managing Director. His research interests are the analysis of global bio-healthcare industry and sustainably growing Bio-Economy and its ecosystem through innovating data and global business development networks.

In the past he was the Director for Center for International Affairs, Division of Biotechnology and Welfare R&D Coordination, and Division of R&D Program Evaluation of Korean government in KISTEP (Korea Institute of Science & Technology Evaluation and Planning) starting from 2006.

He holds a Ph.D. degree from Korea University (Biotechnology and Genetic Engineering) and two M.S. degrees from University of Minnesota (Animal Physiology, USA) and Cornell University (Physiology, USA), and a B.S. degree from Hanyang University in Korea.

Some of his contributions include a founding board member of Korea Society for Bio-Economy, a member of International Advisory Council for Global Bioeconomy Council, and a member of Korean Association for Policy Studies.